Compare Tesla, Inc. (TSLA) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tesla, Inc. vs DENTSPLY SIRONA Inc — how do they compare? Tesla, Inc. trades at $365.61 (market cap $1.45T), while DENTSPLY SIRONA Inc trades at $10.7 (market cap $2.19B). The key difference: Tesla, Inc. is far larger — about 662.1× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Tesla, Inc. pays none. Which is the better fit depends on your goals.
| TSLA | XRAY | |
|---|---|---|
Market Cap | $1.45T | $2.19B |
Sector | Consumer Cyclical | Health |
52-Week High | $489.88 | $14.68 |
52-Week Low | $298.16 | $9.64 |
Enterprise Value | $1.43T | $4.26B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tesla (TSLA) trades at $368.16, up 3.98% in the last 24 hours, with a bullish technical signal from moving averages and ADX indicators. Recent earnings show a mix of beats and a miss, with Q2 2026 EPS of $0.33 falling short of the $0.50 estimate. The company's revenue declined to $94.83 billion in 2025, and net income margin compressed to 3.67%, while valuation ratios like P/E of 340.89 remain elevated. Positive news includes regulatory approval for self-driving software in Europe and a surge in German registrations.
Tesla's outlook hinges on execution in autonomous driving and energy segments, but high valuation and margin pressures pose risks. Analyst consensus is mixed with a $398.38 price target, suggesting moderate upside, though competition and demand volatility require caution for investors.
XRAY trades at $10.99, down 3.43% on the day, reflecting ongoing challenges amid a bearish technical signal. The company reported a Q2 2026 earnings beat but faces declining revenue and negative profitability, with a net income margin of -14.99%. Cash flow trends show volatility, and the debt-to-asset ratio has worsened to 42.88% in 2025. Recent news highlights margin pressure and a class-action lawsuit inquiry, clouding the near-term outlook despite some institutional buying interest.
The investment outlook is cautious. While the stock trades below the consensus price target of $12.50, persistent net losses, high debt, and competitive pressures pose significant risks. Analyst sentiment is mixed with a 'Hold' consensus, suggesting limited upside until the company demonstrates sustained operational improvement and revenue stabilization.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
